ArticleEuropean journal of medical research2022

Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.

Lili Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.